Host Immune Response to Novel RNA COVID-19 Vaccination
NCT04784689
·
clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
COVID-19 Vaccine
Cancer
Interventions
BIOLOGICAL:
COVID-19 Vaccine
Sponsor
The University of Texas Health Science Center at San Antonio